In addition, ISMP recommends dispensing, when appropriate, the weekly dosage pack (Wyeth's Rheumatrix Dose Pack); it provides an additional tool for avoiding confusion over the dosage schedule.

Immunocompromised people and those who are age 65 or older should get a second dose of the 2024-2025 COVID-19 vaccine, according to the latest recommendations from the Centers for Disease Control ...

In its latest guidance, released Wednesday, the CDC recommends that adults aged 65 and older, as well as individuals with weakened immune systems, receive a second dose of the updated vaccine six ...

Immunocompromised adults or those who are older than 65 should get a second dose of the latest COVID-19 vaccine, the Centers for Disease Control and Prevention (CDC) officially recommended.

Recommendation comes after recent FDA approval and positive CHMP Opinion for ribociclib (Kisqali) to help reduce the risk of recurrence in EBC. (Image Credits: Pexels) The NCCN Clinical Practice ...

As a new patch fixes dozens of bugs and makes significant changes to the road and traffic systems, Colossal Order finally confirms that the much-anticipated first Cities Skylines 2 region pack is ...

The National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines for breast cancer, providing a boost to Novartis' (NOVN: VX) Kisqali (ribociclib). The new guidelines make ...

PACK EXPO International 2024 (Nov. 3–6; McCormick Place, Chicago), will showcase a wide array of innovations to help brand owners minimize energy consumption, waste, and carbon footprint and address ...

Data from the pivotal trial also showed that Kisqali's safety profile at the 400mg dose was well-tolerated, with generally low-grade symptomatic adverse events. Following the CHMP’s positive ...

The dosage may vary. Clonazepam tablets are approved by the Food and Drug Administration (FDA) to treat: Seizure disorder in adults and children. It can be taken alone or with other drugs for ...

Levothyroxine comes in several forms. The dosage can vary depending on what condition the drug is used to treat. Levothyroxine intravenous (IV) injection is approved by the FDA to treat myxedema ...

Your health care provider may tell you to decrease your dose, temporarily stop, or completely stop taking KISQALI if you develop certain serious side effects during treatment with KISQALI. What should ...